Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: Final results from the International Active Surveillance Study of Women Taking Oral Contraceptives

Contraception

Volumn 89, Issue 4, 2014, Pages 253-263

  Dinger, Jürgen ^a   Bardenheuer, Kristina ^a   Heinemann, Klaas ^a  

^a ZEG Berlin Center for Epidemiology and Health Research   (Germany)

Author keywords

ATE; Prospective cohort study; Routine clinical practice; SAE; VTE

Indexed keywords

DESOGESTREL; DROSPIRENONE PLUS ETHINYLESTRADIOL; GESTODENE; LEVONORGESTREL; DROSPIRENONE; ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT; ANDROSTANE DERIVATIVE; MINERALOCORTICOID ANTAGONIST;

ARTERIAL THROMBOEMBOLISM; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG FATALITY; DRUG SAFETY; FATALITY; FEMALE; FEMALE FERTILITY; FOLLOW UP; GROUPS BY AGE; HORMONAL CONTRACEPTION; HUMAN; HUMAN EXPERIMENT; INCIDENCE; LONG TERM CARE; NEOPLASM; ORAL CONTRACEPTION; OUTCOME ASSESSMENT; PHYSICIAN; TREATMENT DURATION; TREATMENT FAILURE; UNITED STATES; VENOUS THROMBOEMBOLISM; ACUTE HEART INFARCTION; CARDIOVASCULAR RESPONSE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DRUG DOSE REGIMEN; DRUG EFFECT; EUROPE; EUROPEAN; LUNG EMBOLISM; MULTICENTER STUDY; PROSPECTIVE STUDY; ADULT; CHEMICALLY INDUCED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; YOUNG ADULT;

ADULT; ANDROSTENES; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84897108317     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2014.01.023     Document Type: Article

References (33)

1. D.A. Grimes Epidemiologic research using administrative databases; author's reply Am J Obstet Gynecol 117 2011 411
2. T. Rabe, B. Luxembourg, M. Ludwig, J. Dinger, R. Bauersachs, and H. Rott et al. Contraception and thrombophilia - a statement from the German Society for Gynecological Endocrinology and Reproductive Medicine (DGGEF e.V.) and the Professional Association of German Gynaecologists J Reproduktionsmed Endokrinol 8 2011 126 167
3. J.C. Dinger, L.A.J. Heinemann, and D. Kühl-Habich The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation Contraception 75 2007 344 354
4. M. Susser What is a cause and how do we know one? A grammar for pragmatic epidemiology Am J Epidemiol 133 1991 635 648
5. K.J. Rothman, and C. Poole A strengthening programme for weak associations Int J Epidemiol 17 1988 955 959
6. M.J. Khoury, L.M. James, W.D. Flanders, and J.D. Erickson Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogens Teratology 46 1992 69 77
7. S. Shapiro Bias in the evaluation of low-magnitude associations: an empirical perspective Am J Epidemiol 151 2000 939 945
8. S. Shapiro Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy. Part 2. Principles of causality in epidemiological research: confounding, effect modification and strength of association J Fam Plann Reprod Health Care 34 2008 185 190
9. S. Shapiro Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy. Part 3: principles of causality in epidemiological research: statistical stability, dose- and duration response effects, internal and external consistency, analogy and biological plausibility J Fam Plann Reprod Health Care 34 2008 261 264
10. G. Taubes Epidemiology faces its limits Science 269 1995 164 169
11. A.B. Hill The environment and disease: association or causation? Proc R Soc Med 58 1965 295 300
12. S. Suissa, L. Blais, W.O. Spitzer, J. Cusson, M. Lewis, and L. Heinemann First-time use of newer oral contraceptives and the risk of venous thromboembolism Contraception 56 1997 141 146
13. S. Suissa, W.O. Spitzer, B. Rainville, J. Cusson, M. Lewis, and L. Heinemann Recurrent use of newer oral contraceptives and the risk of venous thromboembolism Hum Reprod 15 2000 817 821
14. J.H. Scurr, S.J. Machin, S. Bailey-King, I.J. Mackie, S. McDonald, and P.D.C. Smith Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial Lancet 357 2001 1485 1489
15. C. Belcaro, G. Geroulakos, A.N. Nicolaides, K.A. Myers, and M. Winford Venous thromboembolism from air travel: the LONFLIT Study Angiology 52 2001 369 374
16. T. Schwarz, G. Siegert, W. Oettler, K. Halbritter, J. Beyer, and R. Frommhold et al. Venous thrombosis following long-haul flights Arch Intern Med 163 2003 2759 2764
17. I.D. Bezemer, F.J. van der Meer, J.C. Eikenboom, F.R. Rosendaal, and C.J. Doggen The value of family history as a risk indicator for venous thrombosis Arch Intern Med 169 2009 610 615
18. J.D. Seeger, J. Loughlin, P.M. Eng, C.R. Clifford, J. Cutone, and A.M. Walker Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives Obstet Gynecol 110 2007 587 593
19. J.C. Dinger, K. Voigt, and S. Moehner Case-control study: use of oral contraceptives containing dienogest and risk of venous thromboembolism Pharmacoepidemiol Drug Saf 18 2009 S114
20. E. Lidegaard, E. Løkkegaard, A.L. Svendsen, and C. Agger Hormonal contraception and risk of venous thromboembolism: national follow-up study BMJ 339 2009 b2890
21. S. Sidney, T.C. Cheetham, F.A. Connell, R. Ouellet-Hellstrom, D.J. Graham, and D. Davis et al. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users Contraception 87 2013 93 100
22. S.S. Jick, and R.K. Hernandez Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data BMJ 340 2011 d2151
23. L. Parkin, K. Sharples, R.K. Hernandez, and S.S. Jick Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database BMJ 340 2011 d2139
24. Vlieg A. Van Hylckama, F.M. Helmerhorst, J.P. Vandenbroucke, C.J.M. Doggen, and F.R. Rosendaal The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study BMJ 339 2009 b2921
25. J. Dinger, and S. Shapiro Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets J Fam Plann Reprod Health Care 38 2012 2 6
26. J.T. Jensen, and J. Trussell Communicating risk: does scientific debate compromise safety? Contraception 86 2012 551 556
27. R.L. Reid, C. Westhoff, D. Mansour, C. de Vries, J. Verhaeghe, and E. Boschitsch et al. Oral contraceptives and venous thromboembolism consensus opinion from an international workshop held in Berlin, Germany in December 2009 J Fam Plann Reprod Health Care 36 2010 117 122
28. D.A. Grimes Epidemiologic research using administrative databases: garbage in, garbage out Obstet Gynecol 116 2010 1018 1019
29. J. Dinger Oral contraceptives and venous thromboembolism: old questions revisited J Fam Plann Reprod Health Care 35 2009 211 213
30. S. Shapiro Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases J Fam Plann Reprod Health Care 39 2013 89 96 10.1136/jfprhc-2012-100577
31. M.T. Severinsen, S.R. Kristensen, K. Overvad, C. Dethlefsen, A. Tjønneland, and S.P. Johnsen Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution J Clin Epidemiol 63 2010 223 228
32. ∅. Lidegaard, L.H. Nielsen, C.W. Skovlund, and E. Løkkegaard Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 BMJ 344 2012 e2990
33. O. Lidegaard, E. Lokkegaard, A. Jensen, C.W. Skovlund, and N. Keiding Thrombotic stroke and myocardial infarction with hormonal contraception N Engl J Med 366 2012 2257 2266